OBSEF

OBSEVA SA ACT NOM by ObsEva SA (OBSEF)

About OBSEVA SA ACT NOM by ObsEva SA (OBSEF)

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.

Details

Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
$0.00
52 Week Low
$0.00
Market cap
4,400
Dividend yield
0.00%
Volume
874
Avg. volume
7,358
P/E ratio
--

OBSEVA SA ACT NOM by ObsEva SA News

Details

Daily high
$0.00
Daily low
$0.00
Price at open
$0.00
52 Week High
$0.00
52 Week Low
$0.00
Market cap
4,400
Dividend yield
0.00%
Volume
874
Avg. volume
7,358
P/E ratio
--